Literature DB >> 32369475

[Recommendations of the Society of Gastroenterology of Peru to avoid the spread of SARS-CoV-2 through digestive endoscopy procedures].

Ricardo Arturo Prochazka Zá Rate1, María Cecilia Cabrera Cabrejos2, Alejandro Piscoya3, Augusto Francisco Vera Calderón4.   

Abstract

The SARS-CoV-2 coronavirus produces the disease called COVID-19, currently spreading in a rapidly evolving pandemic. It can be transmitted by contact, drops and aerosols, and has been isolated from gastrointestinal secretions and faeces. During digestive endoscopy, transmission by any of these mechanisms could occur. It is recommended to limit digestive endoscopy to cases of digestive bleeding, severe dysphagia, foreign body in the digestive tract, biliary obstruction with intractable pain or cholangitis, pseudocyst or complicated encapsulated pancreatic necrosis, gastrointestinal obstruction, and cases at risk of deterioration over time. It is recommended to screen patients based on temperature, symptoms, and epidemiological factors to classify them according to their risk of infection. For procedures in low risk patients, personnel must wear a disposable gown, gloves, eye or face shield, standard surgical mask, disposable hat, disposable shoe covers. In cases of intermediate or high risk, or confirmed COVID-19, protection should be increased using disposable waterproof gown, N95 respirator or similar, and double glove. In case of shortage it may be necessary to reuse N95 respirators for up to 5 uses, following CDC recommendations for donning, removing and storing to prevent secondary contact contamination. Likewise, all protective equipment should be put on and removed according to CDC recommendations. The presence of personnel in endoscopy should be limited to the bare minimum. Said personnel must have daily temperature control and if it is above 37.3ºC, the corresponding evaluation must be carried out. After each procedure, the stretcher and room surfaces should be properly disinfected. High-level disinfection of endoscopes eliminates SARS-CoV-2.

Entities:  

Mesh:

Year:  2020        PMID: 32369475

Source DB:  PubMed          Journal:  Rev Gastroenterol Peru        ISSN: 1022-5129


  4 in total

Review 1.  The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment.

Authors:  Kuldeep Dhama; Shailesh Kumar Patel; Rakesh Kumar; Rupali Masand; Jigyasa Rana; Mohd Iqbal Yatoo; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Senthilkumar Natesan; Manish Dhawan; Tauseef Ahmad; Talha Bin Emran; Yashpal Singh Malik; Harapan Harapan
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-15       Impact factor: 4.223

2.  Adherence to recommendations for endoscopy practice during COVID-19 pandemic in Latin America: how are we doing it?

Authors:  Enrique Murcio-Pérez; Raúl Antonio Zamarripa-Mottú; Gustavo Andrade-DePaulo; Octavio Aguilar-Nájera; Jorge Asadur Tchekmedyian; Gerardo Blanco-Velasco; Omar Michel Solórzano-Pineda; Oscar Victor Hernández-Mondragón; Felix Tellez-Avila
Journal:  BMJ Open Gastroenterol       Date:  2021-01

3.  Influence of Standardized Nursing Management of Hospital Based on Smart Electronic Medical Blockchain on Nursing Quality of Digestive Endoscopy Room.

Authors:  Yufen Niu
Journal:  J Healthc Eng       Date:  2021-04-26       Impact factor: 2.682

Review 4.  Clinical Questions and Answers on Gastrointestinal Endoscopy during the Novel Coronavirus Disease 2019 pandemic.

Authors:  Takahisa Furuta; Atsushi Irisawa; Takayuki Matsumoto; Takashi Kawai; Tomoki Inaba; Atsushi Kanno; Akio Katanuma; Yoshiro Kawahara; Koji Matsuda; Kazuhiro Mizukami; Takao Otsuka; Ichiro Yasuda; Mitsuhiro Fujishiro; Shinji Tanaka; Kazuma Fujimoto; Shinsaku Fukuda; Hiroyasu Iishi; Yoshinori Igarashi; Kazuo Inui; Toshiharu Ueki; Haruhiko Ogata; Mototsugu Kato; Akiko Shiotani; Kazuhide Higuchi; Naotaka Fujita; Kazunari Murakami; Hironori Yamamoto; Tohru Ito; Kazuichi Okazaki; Yuko Kitagawa; Tetsuya Mine; Hisao Tajiri; Haruhiro Inoue
Journal:  Dig Endosc       Date:  2020-07       Impact factor: 6.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.